Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 14, 2014 - Issue 2
Submit an article Journal homepage
144
Views
11
CrossRef citations to date
0
Altmetric
Reviews

Relationship between modeling technique and reported outcomes: case studies in models for the treatment of schizophrenia

Birgitta von SchéeleRTI Health Solutions, Lund, Sweden
,
Josephine MauskopfRTI Health Solutions, Research Triangle Park, NC 27707, USACorrespondence[email protected]
,
Thor-Henrik BrodtkorbRTI Health Solutions, Lund, Sweden
,
Claire AinsworthRTI Health Solutions, Manchester, UK
,
Carmen Galani BerardoF Hoffmann-La Roche Ltd, Basel, Switzerland
&
Anita PatelInstitute of Psychiatry, King's College, London, UK
Pages 235-257 | Published online: 25 Feb 2014

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Junwen Zhou, Aurélie Millier, Clément François, Samuel Aballéa & Mondher Toumi. (2019) Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results. Journal of Market Access & Health Policy 7:1.
Read now
Junwen Zhou, Aurélie Millier & Mondher Toumi. (2018) Systematic review of pharmacoeconomic models for schizophrenia. Journal of Market Access & Health Policy 6:1.
Read now

Articles from other publishers (8)

Michelle Tew, Michael Willis, Christian Asseburg, Hayley Bennett, Alan Brennan, Talitha Feenstra, James Gahn, Alastair Gray, Laura Heathcote, William H. Herman, Deanna Isaman, Shihchen Kuo, Mark Lamotte, José Leal, Phil McEwan, Andreas Nilsson, Andrew J. Palmer, Rishi Patel, Daniel Pollard, Mafalda Ramos, Fabian Sailer, Wendelin Schramm, Hui Shao, Lizheng Shi, Lei Si, Harry J. Smolen, Chloe Thomas, An Tran-Duy, Chunting Yang, Wen Ye, Xueting Yu, Ping Zhang & Philip Clarke. (2021) Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life Challenge. Medical Decision Making 42:5, pages 599-611.
Crossref
Huajie Jin, Paul Tappenden, Stewart Robinson, Evanthia Achilla, David Aceituno & Sarah Byford. (2020) Systematic review of the methods of health economic models assessing antipsychotic medication for schizophrenia. PLOS ONE 15:7, pages e0234996.
Crossref
Huajie Jin, Paul Tappenden, Stewart Robinson, Evanthia Achilla, James H. MacCabe, David Aceituno & Sarah Byford. (2020) A Systematic Review of Economic Models Across the Entire Schizophrenia Pathway. PharmacoEconomics 38:6, pages 537-555.
Crossref
Shiyong Liu, Yan Li, Konstantinos P. Triantis, Hong Xue & Youfa Wang. (2020) The Diffusion of Discrete Event Simulation Approaches in Health Care Management in the Past Four Decades: A Comprehensive Review. MDM Policy & Practice 5:1, pages 238146832091524.
Crossref
Josephine Mauskopf. (2019) Multivariable and Structural Uncertainty Analyses for Cost-Effectiveness Estimates: Back to the Future. Value in Health 22:5, pages 570-574.
Crossref
Liang Lin, Ying J. Zhao, Hui J. Zhou, Ai L. Khoo, Monica Teng, Lay B. Soh, Boon P. Lim & Kang Sim. (2016) Comparative cost-effectiveness of 11 oral antipsychotics for relapse prevention in schizophrenia within Singapore using effectiveness estimates from a network meta-analysis. International Clinical Psychopharmacology 31:2, pages 84-92.
Crossref
J. Jaime Caro, Jörgen Möller, Jonathan Karnon, James Stahl & Jack Ishak. 2015. Discrete Event Simulation for Health Technology Assessment. Discrete Event Simulation for Health Technology Assessment 256 273 .
Josephine Mauskopf. (2014) Modelling Technique, Structural Assumptions, Input Parameter Values: Which Has the Most Impact on the Results of a Cost-Effectiveness Analysis?. PharmacoEconomics 32:6, pages 521-523.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.